Private equity firm Segulah has announced it is looking to sell its complete stake in Medstop Group Holding AB, whose pharmacy chain holds a 7.5 percent share of the Swedish pharmacy market, to Oriola-KD Holdings Sverige AB. The deal will result in Oriola’s possession of about 300 pharmacies around the nation, increasing its stake in the market from 14 percent to about 21 percent. Segulah originally acquired its 100 percent stake in the Medstop pharmacy chain as part of the privatization of Apoteket AB, a former pharmacy monopoly, in February 2010.
Featured News
Realtors Group to Pay $52 Million to Settle Homebuyer Antitrust Claims
Apr 10, 2026 by
CPI
Delaware Wants to be the Regulatory Home for Stablecoins
Apr 10, 2026 by
CPI
Bessent, Powell Summon Bank CEOs Over Anthropic’s New AI Model
Apr 10, 2026 by
CPI
Florida Attorney General Launches Investigation Into OpenAI and ChatGPT
Apr 9, 2026 by
CPI
Chainalysis Sees Stablecoins Becoming Core Global Payment Infrastructure
Apr 9, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Competitor Collaborations
Mar 26, 2026 by
CPI
Between Scylla and Charybdis – Navigating Transatlantic Antitrust Currents
Mar 26, 2026 by
Tilman Kuhn & Niklas Brüggemann
Cartel Enforcement Moves Into the Labor Market: Trends and Implications
Mar 26, 2026 by
Andreas Kafetzopoulos & Caroline Janssens
Rethinking Buy-Side Antitrust “Group Boycotts”
Mar 26, 2026 by
Craig Falls & Brendan McGuire
Positive Collaborations: The Tools Available to Competition Authorities to Encourage Beneficial Interactions Between Competitors
Mar 26, 2026 by
Rona Bar-Isaac & Thomas Withers